{
   "title": "Revenue of Johnson & Johnson 's pharmaceuticals segment worldwide 2012 to 2024",
   "labels": [
      "Year",
      "Immunology",
      "Cardiovascular/Metabolism/Other",
      "Oncology",
      "Central nervous system",
      "Anti-infectives"
   ],
   "columnType": "multi",
   "graphType": "line",
   "summaryType": "baseline",
   "summary": [
      "You are viewing a chart of multi-line type with 5 lines denoting Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives. The y axis indicates the Revenue in billion U.S. dollars and the x axis indicates Year.",
      "Overall Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives are roughly constant,  throughout the Year",
      "Throughout the period, Oncology generally had the highest Revenue in billion U.S. dollars relative to others with an average of 83.81, and it reached its maximum at 2019 with a value of 988.0.",
      "After Oncology, Immunology overall has the second highest values , with a mean value of 10.8, peaking at 2019. ",
      "The botommost line, Anti-infectives,  has a mean of 4.16, and peaked at 2024. "
   ],
   "xAxis": "Year",
   "yAxis": "Revenue in billion U.S. dollars",
   "min_summary": [
      "This is a multi-line chart with 5 lines representing Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives. The y axis denotes Revenue in billion U.S. dollars and the x axis denotes Year.",
      "Overall Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives are roughly constant,  throughout the Year",
      "Throughout the period, Oncology generally had the highest Revenue in billion U.S. dollars relative to others with an average of 83.81, and it reached its maximum at 2019 with a value of 988.0.",
      "Followed by Immunology which ranks as the second topmpost line , with an average of 10.8 Revenue in billion U.S. dollars,reaching its highest point  at 2019 with a value of 12.4. ",
      "Anti-infectives mostly had the least Revenue in billion U.S. dollars with a mean value of 4.16, which peaked at 2024 with a value of 5.94. "
   ],
   "mid_summary": [
      "You are viewing a chart of multi-line type with 5 lines denoting Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives. The y axis indicates the Revenue in billion U.S. dollars and the x axis indicates Year.",
      "Overall Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives are roughly constant,  throughout the Year",
      "Throughout the period, Oncology generally had the highest Revenue in billion U.S. dollars relative to others with an average of 83.81, and it reached its maximum at 2019 with a value of 988.0.",
      "After Oncology, Immunology overall has the second highest values , with a mean value of 10.8, peaking at 2019. ",
      "The botommost line, Anti-infectives,  has a mean of 4.16, and peaked at 2024. "
   ],
   "max_summary": [
      "You are viewing a chart of multi-line type with 5 lines denoting Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives. The y axis indicates the Revenue in billion U.S. dollars and the x axis indicates Year.",
      "Overall Immunology, Cardiovascular/Metabolism/Other, Oncology, Central nervous system, and Anti-infectives are roughly constant,  throughout the Year",
      "Overall across the Year, Oncology mostly maintained the highest Revenue in billion U.S. dollars when compared to others with a mean value of 83.81, and it peaked at 2019.",
      "Followed by Immunology which ranks as the second topmpost line , with an average of 10.8 Revenue in billion U.S. dollars,reaching its highest point  at 2019 with a value of 12.4. ",
      "The botommost line, Anti-infectives,  has a mean of 4.16, and peaked at 2024. ",
      "Oncology reported the lowest Revenue in billion U.S. dollars about 2.63 in Year 2012"
   ],
   "trends": [
      {},
      {
         "2": [
            "0",
            "2"
         ],
         "16": [
            "12",
            "2"
         ]
      },
      {
         "1": [
            "7",
            "2"
         ],
         "9": [
            "7",
            "2"
         ]
      },
      {
         "2": [
            "0",
            "0"
         ],
         "15": [
            "12",
            "0"
         ]
      },
      {
         "1": [
            "7",
            "0"
         ],
         "10": [
            "7",
            "0"
         ]
      }
   ],
   "data": [
      {
         "Year": "2012",
         "Immunology": "7.87",
         "Cardiovascular/Metabolism/Other": "4.94",
         "Oncology": "2.63",
         "Central nervous system": "6.72",
         "Anti-infectives": "3.19"
      },
      {
         "Year": "2013",
         "Immunology": "9.19",
         "Cardiovascular/Metabolism/Other": "4.95",
         "Oncology": "3.77",
         "Central nervous system": "6.67",
         "Anti-infectives": "3.55"
      },
      {
         "Year": "2014",
         "Immunology": "10.19",
         "Cardiovascular/Metabolism/Other": "5.58",
         "Oncology": "4.46",
         "Central nervous system": "6.49",
         "Anti-infectives": "5.6"
      },
      {
         "Year": "2015",
         "Immunology": "10.4",
         "Cardiovascular/Metabolism/Other": "6.42",
         "Oncology": "4.7",
         "Central nervous system": "6.26",
         "Anti-infectives": "3.66"
      },
      {
         "Year": "2016",
         "Immunology": "11.97",
         "Cardiovascular/Metabolism/Other": "6.4",
         "Oncology": "5.81",
         "Central nervous system": "6.08",
         "Anti-infectives": "3.21"
      },
      {
         "Year": "2017",
         "Immunology": "12.24",
         "Cardiovascular/Metabolism/Other": "6.29",
         "Oncology": "7.26",
         "Central nervous system": "5.99",
         "Anti-infectives": "3.15"
      },
      {
         "Year": "2018",
         "Immunology": "12.34",
         "Cardiovascular/Metabolism/Other": "7.19",
         "Oncology": "8.96",
         "Central nervous system": "5.74",
         "Anti-infectives": "3.18"
      },
      {
         "Year": "2019",
         "Immunology": "12.49",
         "Cardiovascular/Metabolism/Other": "7.27",
         "Oncology": "988.0",
         "Central nervous system": "4.93",
         "Anti-infectives": "3.79"
      },
      {
         "Year": "2020",
         "Immunology": "12.09",
         "Cardiovascular/Metabolism/Other": "7.1",
         "Oncology": "10.73",
         "Central nervous system": "4.84",
         "Anti-infectives": "3.95"
      },
      {
         "Year": "2021",
         "Immunology": "11.69",
         "Cardiovascular/Metabolism/Other": "7.09",
         "Oncology": "11.78",
         "Central nervous system": "4.94",
         "Anti-infectives": "4.38"
      },
      {
         "Year": "2022",
         "Immunology": "11.14",
         "Cardiovascular/Metabolism/Other": "6.93",
         "Oncology": "12.71",
         "Central nervous system": "5.05",
         "Anti-infectives": "5.02"
      },
      {
         "Year": "2023",
         "Immunology": "10.24",
         "Cardiovascular/Metabolism/Other": "6.8",
         "Oncology": "13.91",
         "Central nervous system": "4.68",
         "Anti-infectives": "5.45"
      },
      {
         "Year": "2024",
         "Immunology": "9.34",
         "Cardiovascular/Metabolism/Other": "6.79",
         "Oncology": "14.86",
         "Central nervous system": "5.03",
         "Anti-infectives": "5.94"
      }
   ]
}